Perimenopause · Ranked · 2026
The midlife shift toward more central fat and less lean mass is measured, not imagined — and it's exactly the machinery GLP-1 medicines act on. But perimenopause layers hormonal symptoms on top, so oversight and labs matter more here, not less. We ranked GLP-1 telehealth on that basis.
The short answer
CoreAge Rx, a featured partner, scores 86/100 — a clinician who reads your history, labs in the loop, and both molecules on one flat-priced account, which counts when midlife insulin resistance is driving the change. Providers we work with may appear first.
6 providers. CoreAge Rx is a featured partner; providers we work with may appear first. The Metabolic-Fit Score is printed on every row so you can check it.
CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
Semaglutide from $129 and tirzepatide from $179 a month, all doses included — a reasonable option if you can live with a yearly plan, a month-to-month price you only see at checkout, and a pharmacy it doesn't name.
A compounded program that advertises ongoing provider care, metabolic testing every six months and shipping within its price. Semaglutide is $249 and tirzepatide $329 every four weeks without a longer commitment; lower equivalents require 12-, 24- or 48-week terms. Microdose and combination options need separate current quotes.
The closest thing here to a real obesity-medicine clinic online — board-certified physicians and registered dietitians, monthly video visits, and a real effort to work brand-name drugs through insurance. The $299 self-pay fee is for that clinical team, not the medication.
A women's-health practice first and a GLP-1 prescriber second: an OB-GYN or nurse practitioner, a registered dietitian and hormone labs on every case, check-ins every one to two weeks, and brand-name options from the Wegovy tablet to Zepbound. The $149 a month buys the care team, not the medication, which your own pharmacy and insurance price. Full care runs in 45 states plus DC; five more states get nutrition-only care with no prescribing.
| # | Provider | From | Score | |
|---|---|---|---|---|
| 1 | CoreAge Rx | $79/mo | See review | 86 · B |
| 2 | Gala Health | See review | All 50 states | 84 · B |
| 3 | Enhance MD | $249/4 wk | 40 states | 81 · B− |
| 4 | Form Health | See review | See review | 86 · B |
| 5 | Ro | See review | See review | 84 · B |
| 6 | Allara Health | See review | 45 states | 81 · B− |
On the Metabolic-Fit Score, CoreAge Rx, a featured partner, scores 86/100: a real clinician who reads your history, labs in the loop, flat nationwide pricing, and both semaglutide and tirzepatide on one account — which matters when midlife insulin resistance shifts fat toward the middle. Oversight and hormonal fit are weighted heavily because perimenopause layers hormonal symptoms on top of metabolic ones.
Not as perimenopause-specific trials. The large obesity studies enrolled many midlife women and showed strong average weight loss, so it's fair to say the medications work in this age group — but not that they were tested against the hormonal transition itself. Our ranking rewards providers that check thyroid and glucose markers and can coordinate with whoever manages any hormone therapy, rather than treating a number on the scale in isolation.
Yes, and the two molecules differ. Pregnancy happens in early perimenopause, and GLP-1 medicines are not used in pregnancy or while trying to conceive. The semaglutide label asks you to stop at least two months before a planned pregnancy — that is the instruction, not the roughly-a-week half-life that often gets quoted in its place. Tirzepatide's label sets no pre-pregnancy window at all and instead says to stop once a pregnancy is recognized, but it does reduce the efficacy of oral hormonal contraceptives for four weeks after starting and after each dose increase. A provider that raises contraception and timing up front scores better here than one that ships a vial and moves on.
Every provider is scored on six women's-health factors — MomMetabolic's Metabolic-Fit Score — led by clinical oversight and hormonal fit for this stage. Some outbound links earn a referral fee; commissions don't change a provider's score. CoreAge Rx is a featured partner; providers we work with may appear first.
Rankings reflect our published methodology. This page is informational and not medical advice; compounded medications are not FDA-approved brand products, and GLP-1 medicines are not used in pregnancy or while trying to conceive. See our medical disclaimer. Some links here earn us a referral fee, walled off from the score — read our funding disclosure.
Keep exploring
Each board answers a different question a mother brings to GLP-1 care.